IRA Overhauls Medicare Coverage and Drug Pricing Structure
The latest in this situation
How it started
What happened
The Inflation Reduction Act has caused fundamental changes to Medicare coverage and drug pricing. Insurance companies are making radical changes, including potential premium increases and changes to drug tiers. The Act required Medicare to negotiate drug prices with pharmaceutical companies, leading to a 3.1% annual decline in prescription drug costs since 1963.
Why it matters
The changes fundamentally alter the financial structure of the Medicare program. The drug price negotiation limits beneficiaries' out-of-pocket prescription costs to a maximum of $2,400. However, while drug costs have declined, other medical care costs, such as hospital services, have continued to rise.
Who's involved
- MedicareUS federal health insurance program that is being restructured by the IRA.
- CMSAdministrative body responsible for implementing and regulating the federal Medicare health insurance program.
- Donald TrumpPolitician who issues policy directives that the administrative body is required to implement.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- PfizerSpeculative
Regulatory action might impose a hard price ceiling on net sales.
- Johnson & JohnsonSpeculative
Regulatory action might impose a hard price ceiling on net sales.
- Neurocrine BiosciencesSpeculative
Regulatory action might impose a hard price ceiling on net sales.
- PublixSpeculative
Lower prescription drug costs might reduce retail sales pressure.
Possible ripples
Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.- Aetna may adjust operations amid IRA's Medicare drug pricing changesAetna may face operational shifts due to IRA's Medicare changesLikely
- New Medicare rules may change Clover Health's financial exposureClover Health may face new cost pressures due to Medicare's structural changesLikely
- Johnson & Johnson's drug pricing faces federal price capsJ&J's drug revenue may face limits due to IRA price negotiationLikely
- Humana may adjust coverage rules amid IRA's Medicare overhaulHumana may face mixed financial exposure due to IRA's Medicare drug pricing changesLikely
- IRA drug price negotiation could reduce Pfizer's net salesIRA's drug price negotiation may reduce Pfizer's net sales revenuePossible
How it developed
Newest first. Tap a step to see who reported it.- IRA withdrawal causes MAGI increase, leading to Medicare surcharge.Sub-event
- Guidehouse faces regulatory pressures stemming from the Inflation Reduction Act.Sub-event
IRA accelerates federal control over drug pricing.1 source
- Medicare enrollment moratorium affects local providers.Sub-event
- Medicare approved New Hampshire's spending plan.Sub-event
IRA drives market changes in drug pricing and financing models.1 source
The Inflation Reduction Act (IRA) caused fundamental changes to Medicare.1 source
Keep exploring
The entities involved
Related events
- Paul Ryan proposed reforms to trim the deficit in 2011.
- Margaret faces Medicare surcharges due to high income while receiving retirement income strategies from Fisher Investments.
- Medicare lookback rules are eroding the financial gains associated with Roth conversions.
- Debate focused on Medicare for All policy in the Senate.
Coverage
Newest first; wire copies grouped- bozemandailychronicle.com
- courierjournal.net
- phillyvoice.com
- theleader.com.auIs the Liberal era done?
- mondaq.com
- jdsupra.com
- naco.org